Group 1 - The company Shenzhen Weiguang Biological Products Co., Ltd. has approved its wholly-owned subsidiary to participate in the establishment of an investment fund, with a total fund size of RMB 55 million [2] - Weiguang Investment, as a limited partner, will contribute RMB 16.5 million, holding a 30% share in the partnership [2] - The investment fund named Shenzhen Guangming Qihang New Journey Private Equity Investment Fund Partnership (Limited Partnership) has completed its business registration and obtained a business license [3] Group 2 - The fund's business license was issued by the Shenzhen Market Supervision Administration Guangming Regulatory Bureau, with the establishment date being February 6, 2026 [3] - The main business activities of the fund include private equity investment, investment management, and asset management, subject to registration with the Asset Management Association of China [3]
深圳市卫光生物制品股份有限公司 关于全资子公司参与设立投资基金的进展公告